Sickle Cell Disease (SCD)

Standard of Care Comparative Arm of Phase 1/2 Gene Therapy Trial DREPAMIR" in Severe Sickle Cell Disease Patients

CPAP for Hypoxemic Acute Chest Syndrome in Sickle Cell Disease

Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients

Low Dose Bolus Ketamine For Use In Sickle Cell Pain Crisis

Risk Factors, Costs, and Impacts of ED Boarding

Epidemiology of Invasive Bacterial Infections in Children With Sickle Cell Disease in France Between 2020 and 2025

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease

OMEGA-3-FATTY ACIDS IN CHILDREN WITH SICKLE CELL DISEASE

Sickle Cell Kidney Biorepository

Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire

Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients

An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients

Exploratory Study on Global Reflexology in Sickle Cell Disease

Megakaryocyte Heterogeneity in Sickle Cell Disease

Phenotypic and Transcriptomic Description of Megakaryocytes in Sickle Cell Patient

Relationship Between Biological Phenotype, Clinical Severity of Sickle Cell Disease, and Blood Coagulation

Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Study of ALXN1820 in Adult Participants With Sickle Cell Disease

Optimizing Hydroxyurea Dosage With Pharmakokinetic in Patients Suffering of Moderate to Severe Sickle Cell Anemia